New Key Statistics Module, Z-Score and F-Score
NYSE:WST Key Ratios
Market Cap $ M | 23,868.23 |
Enterprise Value $ M | 23,814.67 |
P/E(ttm) | 48.90 |
PE Ratio without NRI | 48.75 |
Forward PE Ratio | 44.36 |
Price/Book | 8.68 |
Price/Sales | 8.48 |
Price/Free Cash Flow | 75.90 |
Price/Owner Earnings | 57.38 |
Payout Ratio % | 0.12 |
Revenue (TTM) $ M | 2,876.00 |
EPS (TTM) $ | 6.74 |
Beneish M-Score | -2.58 |
10-y EBITDA Growth Rate % | 15.00 |
5-y EBITDA Growth Rate % | 22.00 |
y-y EBITDA Growth Rate % | -6.00 |
EV-to-EBIT | 40.54 |
EV-to-EBITDA | 32.27 |
PEG | 2.22 |
Shares Outstanding M | 72.42 |
Net Margin (%) | 17.37 |
Operating Margin % | 20.44 |
Pre-tax Margin (%) | 20.47 |
Quick Ratio | 2.23 |
Current Ratio | 3.00 |
ROA % (ttm) | 13.61 |
ROE % (ttm) | 18.16 |
ROIC % (ttm) | 18.10 |
Dividend Yield % | 0.25 |
Altman Z-Score | 18.64 |
WST Number of Guru Trades
WST Volume of Guru Trades
Gurus Latest Trades with NYSE:WST
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NYSE:WST is held by these investors
Total 4
West Pharmaceutical Services Inc Insider Transactions
No Available Data
News about NYSE:WST
Total 0- 1